Adidas Cuts Ties With Ye, Absorbing €250 Million Profit Hit

(Bloomberg) — Adidas AG will absorb a hit to earnings of up to €250 million ($247 million) this year to end its partnership with Ye following a rash of offensive behavior from the rapper and designer.

The German sports company said it’s cutting ties with Ye, formerly Kanye West, with immediate effect, confirming an earlier story by Bloomberg News.

“Ye’s recent comments and actions have been unacceptable, hateful and dangerous, and they violate the company’s values of diversity and inclusion, mutual respect and fairness,” the company said in a statement.

Adidas will terminate the partnership with Ye, end production of Yeezy branded products and stop all payments to Ye and his companies, it said. The decision comes at a price: that line of sneakers accounts for almost half of Adidas’s profits, according to estimates from analysts.

Adidas joins Gap Inc. and Kering SA’s Balenciaga fashion label in severing links with Ye. The rapper has made controversial statements, including antisemitic social media posts in recent weeks, and has moved to cut ties with his corporate partners. Ye didn’t respond to a request for comment.

Adidas shares, already weighed down by the controversy, fell as much as 8.9% in Frankfurt trading, reaching the lowest level since 2016.

 

The Adidas decision follows weeks of deliberations inside the company, which over the past decade has built the Yeezy line — together with Ye — into a brand that’s accounted for as much as 8% of Adidas’s total sales, according to several estimates from Wall Street analysts.

The German company said it’s the “sole owner of all design rights to existing products, as well as previous and new colorways,” under the partnership. It plans to offer more details as part of third-quarter earnings on Nov. 9.

Adidas earlier this month had called the partnership “one of the most successful collaborations in our industry’s history” and said it would continue co-managing Yeezy products during its review.

That success, however, came with plenty of acrimony between the partners. Ye has accused Adidas of copying his ideas and mismanaging the brand, and taunted outgoing Chief Executive Officer Kasper Rorsted on social media. Meanwhile, Adidas has said it repeatedly tried and failed to resolve issues with Ye privately.
The rapper said in September he wanted to negotiate with Adidas to get a 20% royalty on all the shoes he’s designed with the company in perpetuity.

Ye caused more controversy after that by wearing a shirt at the Paris fashion week that said “White Lives Matter.” He later got locked out of his Twitter and Instagram accounts after making repeated antisemitic remarks — remarks that have created a growing backlash from consumers and celebrities, with some calling for people to boycott Adidas products until the partnership is canceled.

The Ye controversy is one of many headaches for Adidas, which is searching for a new CEO to take over in 2023. The company has lowered its earnings forecast several times this year amid falling demand for its shoes and apparel in China and growing signs of economic trouble in Europe and North America.

More stories like this are available on
bloomberg.com

©2022 Bloomberg L.P.

Follow us on social media for the latest updates in B2B!

Image

Latest

Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More
Firefly
Pursuing the Impossible: The New Space Race with Firefly Aerospace Co-Founder Eric Salwan
April 1, 2026

Many companies set out to do something hard. Firefly Aerospace set out to do the impossible. After 10 years and several existential moments, Firefly did what no private company ever had: in 2025, it successfully landed on the Moon. Before Firefly, only countries had ever landed on the Moon—and it took extraordinary national effort…

Read More
internship
Tale of Two Interns: What AI Is Really Doing to Entry-Level Work
March 30, 2026

The narrative around early-career work has become increasingly pessimistic, with headlines pointing to a shrinking pool of entry-level roles, fewer internship opportunities, and AI accelerating both trends. But beneath that narrative, a different tension is emerging—one that’s less about the disappearance of opportunity and more about how it’s being reshaped. Students are using AI…

Read More